[{"id":"58f7d952-0196-4983-aa83-844c0f7f981e","acronym":"","url":"https://clinicaltrials.gov/study/NCT05546255","created_at":"2022-09-19T13:55:50.994Z","updated_at":"2024-07-02T16:36:03.757Z","phase":"Phase 2","brief_title":"Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer","source_id_and_acronym":"NCT05546255","lead_sponsor":"Chinese Academy of Medical Sciences","biomarkers":" HER-2 • ER • PGR","pipe":" | ","alterations":" HER-2 negative • PGR negative","tags":["HER-2 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative • PGR negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Halaven (eribulin mesylate) • lobaplatin (D19466)"],"overall_status":"Recruiting","enrollment":" Enrollment 40","initiation":"Initiation: 06/01/2020","start_date":" 06/01/2020","primary_txt":" Primary completion: 12/01/2022","primary_completion_date":" 12/01/2022","study_txt":" Completion: 12/31/2023","study_completion_date":" 12/31/2023","last_update_posted":"2022-09-19"},{"id":"5eab6bb2-8c2e-40d6-9cb8-58b66a64a9d9","acronym":"WUHIPEC01","url":"https://clinicaltrials.gov/study/NCT04808466","created_at":"2021-03-22T12:52:26.384Z","updated_at":"2024-07-02T16:36:16.838Z","phase":"Phase 2","brief_title":"Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy","source_id_and_acronym":"NCT04808466 - WUHIPEC01","lead_sponsor":"Wuhan Union Hospital, China","biomarkers":" CD8 • IFNG • TNFA • CD4 • IL2","pipe":"","alterations":" ","tags":["CD8 • IFNG • TNFA • CD4 • IL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e paclitaxel • lobaplatin (D19466)"],"overall_status":"Recruiting","enrollment":" Enrollment 231","initiation":"Initiation: 09/18/2021","start_date":" 09/18/2021","primary_txt":" Primary completion: 09/01/2022","primary_completion_date":" 09/01/2022","study_txt":" Completion: 09/01/2025","study_completion_date":" 09/01/2025","last_update_posted":"2022-02-21"},{"id":"6f671258-3f72-476e-bdfe-fe51bfe4e3fe","acronym":"WUHIPEC02","url":"https://clinicaltrials.gov/study/NCT04845490","created_at":"2021-04-15T12:52:58.589Z","updated_at":"2024-07-02T16:36:16.873Z","phase":"Phase 2","brief_title":"Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy","source_id_and_acronym":"NCT04845490 - WUHIPEC02","lead_sponsor":"Wuhan Union Hospital, China","biomarkers":" CD8 • IFNG • TNFA • CD4 • IL2","pipe":"","alterations":" ","tags":["CD8 • IFNG • TNFA • CD4 • IL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e mitomycin • lobaplatin (D19466)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 201","initiation":"Initiation: 09/01/2022","start_date":" 09/01/2022","primary_txt":" Primary completion: 09/01/2023","primary_completion_date":" 09/01/2023","study_txt":" Completion: 09/01/2026","study_completion_date":" 09/01/2026","last_update_posted":"2022-02-21"}]